samedan logo
home > news > detailed info

ACG Films & Foils and Danapak Flexibles A/S enters Strategic Partnership for India

ACG World

Today, ACG, one of the world's most integrated pharmaceutical suppliers, announced its strategic partnership with Danapak Flexibles A/S, the global market leader in packaging for high barrier Transdermal Drug Delivery systems. The partnership will translate into better services to existing and new customers of Danapak Flexibles in India.

ACG Films & Foils and Danapak Flexibles's collective product offerings will now include a broad range of high barrier quality laminates and flexible packaging laminates, including a broad spectrum of suitable alternatives to Barex specifications used for Rivastigmine, Nicotine, Rotigotine, Lidocaine, Fentanyl, Buprenorphine and other APIs.

Confident of the synergies that will stem from the strategic partnership, Mr. L.W Hyldgaard, Managing Director, Danapak Flexibles said, "We are proud to be associated with ACG Films & Foils as our partners in India. Over the years, with innovative solutions and superior customer services, ACG has positioned itself as a formidable player in the global pharmaceutical industry. We are certain this partnership will go a long way and bring better services and more innovative solutions for our customers in India."

Resonating with Mr. Hyldgaard, Mr. S.R Shivshankar, CEO, ACG Films & Foils, said, "We are excited to be chosen for the strategic partnership with Danapak- a brand that is recognized for the best products in its class, globally. With our collective technical expertise and ACG's understanding of the local market, we are confident that together, we will be able to serve the customers with innovative and a wide range of solutions for their high barrier quality laminates requirements."
phone +91 022 7186 2362 / +91 022 7186 2363
email D Bhabrekar Nagar Road Mumbai, Maharashtra 400067, IN
Print this page
Send to a friend
News and Press Releases

Nemera joins IPAC-RS as an Associate Member

Nemera is excited to announce that it has become an Associate Member of the International Pharmaceutical Aerosol Consortium on Regulation & Science (IPAC-RS). Nemera’s decision to join IPAC-RS is part of its commitment to advance science and innovation. Nemera is committed to enhancing better patient outcomes by seeking innovative solutions and contributing actively to discussions about the future of drug delivery devices. Its membership in IPAC-RS will facilitate this important commitment.
More info >>

White Papers

Clinical Trial Labelling – More Than Just Labels

Faubel & Co. Nachfolger GmbH

Deciding which label is best for a particular trial project is not always easy. Labels have become multifunctional tools which are able to convey variable data in different languages, indicate first opening, product originality, support ease of use or blind study drugs. They are no longer used as mere carriers of specified contents.
More info >>

©2000-2011 Samedan Ltd.
Add to favourites

Print this page

Send to a friend
Privacy statement